Moderna, Inc. Profile Avatar - Palmy Investing

Moderna, Inc.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the Uni…
Biotechnology
US, Cambridge [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

FY Quarter Lobby Expense [in mil. $] Filing Report Time
2024 3 5 LDA-2 Oct. 21, 2024, 6:27 p.m.
2024 3 4 LDA-2 Oct. 21, 2024, 2:27 p.m.
2024 3 8 LDA-2 Oct. 17, 2024, 6:04 p.m.
2024 3 3 LDA-2 Oct. 14, 2024, 7:56 p.m.
2023 3 8 LDA-2 Sept. 18, 2024, 2:40 p.m.
2024 2 5 LDA-2 July 22, 2024, 10:39 p.m.
2024 2 4 LDA-2 July 22, 2024, 10:08 a.m.
2024 2 8 LDA-2 July 16, 2024, 10:14 p.m.
2024 2 3 LDA-2 July 15, 2024, 5:38 p.m.
2024 1 5 LDA-2 April 22, 2024, 8:37 p.m.
2024 1 4 LDA-2 April 22, 2024, 3:53 p.m.
2024 1 8 LDA-2 April 18, 2024, 2:37 p.m.
2024 1 3 LDA-2 April 12, 2024, 6:24 p.m.
2024 1 3 LDA-2 April 2, 2024, 8:08 p.m.
2023 4 5 LDA-2 Jan. 22, 2024, 9:34 p.m.
2023 4 4 LDA-2 Jan. 22, 2024, 8:28 p.m.
2023 4 8 LDA-2 Jan. 18, 2024, 3:52 a.m.
2023 4 3 LDA-2 Jan. 11, 2024, 9:18 p.m.
End of MRNA's Analysis
CIK: 1682852 CUSIP: 60770K107 ISIN: US60770K1079 LEI: - UEI: -
Secondary Listings